Last reviewed · How we verify
Maintenance of Healing Gastroesophageal Reflux — Treatment Landscape & Competitive Intelligence
3 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Aciphex | rabeprazole | Waylis | Proton Pump Inhibitor | Potassium-transporting ATPase | 1999-01-01 | |
| Aciphex | Aciphex | University of Utah | Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3 | |||
| Rabeprazol | Rabeprazol | Janssen-Cilag, S.A. | Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Janssen-Cilag, S.A. · 1 drug in Maintenance of Healing Gastroesophageal Reflux
- University of Utah · 1 drug in Maintenance of Healing Gastroesophageal Reflux
- Waylis · 1 drug in Maintenance of Healing Gastroesophageal Reflux
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Maintenance of Healing Gastroesophageal Reflux:
- Maintenance of Healing Gastroesophageal Reflux treatment updates — RSS
- Maintenance of Healing Gastroesophageal Reflux treatment updates — Atom
- Maintenance of Healing Gastroesophageal Reflux treatment updates — JSON
Cite this brief
Drug Landscape (2026). Maintenance of Healing Gastroesophageal Reflux — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/maintenance-of-healing-gastroesophageal-reflux. Accessed 2026-06-11.
Related
- Maintenance of Healing Gastroesophageal Reflux full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing